Prometheus moves to raise cash hours af­ter PhII da­ta leads to stock surge

Af­ter re­leas­ing bet­ter-than-an­tic­i­pat­ed da­ta on two mid-stage stud­ies Wednes­day morn­ing, Prometheus Bio­sciences’ CEO said the com­pa­ny would “take some time to as­sess” its next fi­nanc­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER